Alpha 2.0
Login Register
» Authors » Abiodun Omokehinde Eseola

Abiodun Omokehinde Eseola

Explore the profile of Abiodun Omokehinde Eseola including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 26
Followers 0
Related Specialties
Biochemistry
Molecular Biology
Chemistry
Top 10 Co-Authors
Oluyomi Stephen Adeyemi
Winfried Plass
Olubunmi Atolani
Kentaro Kato
Ikponmwosa Owen Evbuomwan
Tobiloba Christiana Elebiyo
Chiagoziem A Otuechere
Oluwakemi Josephine Awakan
Damilare Rotimi
Tatsuki Sugi
Published In
Inorg Chem
Biochem Biophys Res Commun
J Biomol Struct Dyn
Comb Chem High Throughput Screen
Yale J Biol Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Elucidation of the anti-plasmodial activity of novel imidazole and oxazole compounds through computational and experimental approaches
Johnson T, Adeyemi O, Adegboyega A, Olomu S, Enokela F, Ibrahim S, et al.
J Biomol Struct Dyn . 2022 Oct; 41(18):9013-9021. PMID: 36310100
The development of resistance to conventional antimalarial therapies, along with the unfavorable impact of the COVID-19 pandemic on the global malaria fight, necessitates a greater focus on the search for...
2.
The anti-parasite action of imidazole derivatives likely involves oxidative stress but not HIF-1α signaling
Adeyemi O, Eseola A, Plass W, Kato K, Otuechere C, Awakan O, et al.
Chem Biol Interact . 2021 Sep; 349:109676. PMID: 34592218
Background: Therapeutic options for toxoplasmosis are limited. This fact underscores ongoing research efforts to identify and develop better therapy. Previously, we reported the anti-parasitic potential of a new series of...
3.
New Series of Imidazoles Showed Promising Growth Inhibitory and Curative Potential Against Trypanosoma Infection
Adeyemi O, Molefe-Nyembe N, Eseola A, Plass W, Shittu O, Yunusa I, et al.
Yale J Biol Med . 2021 Jul; 94(2):199-207. PMID: 34211341
The spp. cause animal and human trypanosomiasis characterized with appreciable health and economic burden mostly in developing nations. There is currently no effective therapy for this parasitic disease, due to...
4.
New imidazoles cause cellular toxicity by impairing redox balance, mitochondrial membrane potential, and modulation of HIF-1α expression
Adeyemi O, Eseola A, Plass W, Otuechere C, Elebiyo T
Biochem Biophys Res Commun . 2020 Jun; 529(1):23-27. PMID: 32560814
Background: Our previous reports demonstrated the prospects of a new series of imidazoles as a source of alternative anti-parasite treatments, thus warranting further studies that include toxicity profiling. Objective: In...
5.
Imidazole derivatives as antiparasitic agents and use of molecular modeling to investigate the structure-activity relationship
Adeyemi O, Eseola A, Plass W, Atolani O, Sugi T, Han Y, et al.
Parasitol Res . 2020 Apr; 119(6):1925-1941. PMID: 32279093
Toxoplasmosis is a common parasitic disease caused by Toxoplasma gondii. Limitations of available treatments motivate the search for better therapies for toxoplasmosis. In this study, we synthesized a series of...
6.
New Imidazole-Based Compounds Active Against Trypanosoma cruzi
Adeyemi O, Molina M, Eseola A, Fonseca-Berzal C, Gomez-Barrio A
Comb Chem High Throughput Screen . 2017 Jan; 20(1):20-24. PMID: 28071587
Background: Current drugs available for the treatment of Chagas disease are fraught with several challenges including severe toxicity and limited efficacy. These factors coupled with the absence of effective drugs...
7.
Syntheses, structures, and fluorescent properties of 2-(1H-imidazol-2-yl)phenols and their neutral Zn(II) complexes
Eseola A, Li W, Gao R, Zhang M, Hao X, Liang T, et al.
Inorg Chem . 2009 Sep; 48(19):9133-46. PMID: 19728689
A series of 2-(imidazole-2-yl)phenol ligands L1-L6 with the general composition 4-R(4)-5-R(3)-6-R(2)-2-(4,5-R(1),R(1)-1H-imidazole-2-yl)phenol (L1: R(1) = C(2)H(5), R(2) = R(3) = R(4) = H; L2: R(1) = C(6)H(5), R(2) = R(3) =...